Stephen R. Macfarlane

Stephen R. Macfarlane is a male healthcare provider who helps people with memory-related issues like Dementia, Alzheimer's Disease, CACH Syndrome, Memory Loss, Obsessive-Compulsive Disorder (OCD), and Vascular Dementia.

Stephen R. Macfarlane uses special skills and treatments to help patients with memory problems. He listens carefully to their concerns and works with them to find the best solutions for their needs.

Patients trust Stephen R. Macfarlane because he communicates in a friendly and caring way. He takes the time to explain things clearly and makes sure patients feel comfortable and understood.

Stephen R. Macfarlane stays updated with the latest medical knowledge and research to provide the best care for his patients. This helps him offer the most effective treatments and solutions for memory-related issues.

Stephen R. Macfarlane works closely with colleagues and other medical professionals to provide comprehensive care for his patients. He values teamwork and collaboration to ensure the best outcomes for those he helps.

Through his work, Stephen R. Macfarlane has positively impacted many patients' lives by improving their memory and quality of life. His dedication to helping others has made a real difference in the health and well-being of those he cares for.

One of Stephen R. Macfarlane's notable publications is "Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial" published in The Journal of Prevention of Alzheimer's Disease on January 12, 2025.

Stephen R. Macfarlane is also involved in a clinical trial called "Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease," which is in Phase 3 and currently active but not recruiting participants.